A cap raise in the making here, the funds are dry. I always wonder how they manage to pump lols, better than they dreamt of I guess, took the loss on the chin.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
